Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-663-8 | CAS number: 67-66-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- publication
- Title:
- The acute toxicity of four trihalomethanes in male and female rats
- Author:
- Chu I, Secours V, Marino I, Villeneuve D
- Year:
- 1 980
- Bibliographic source:
- Toxicology and Applied Pharmacology 52, 351-353
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Chloroform
- EC Number:
- 200-663-8
- EC Name:
- Chloroform
- Cas Number:
- 67-66-3
- Molecular formula:
- CHCl3
- IUPAC Name:
- trichloromethane
- Details on test material:
- Chloroform of purity > 99 % obtained from Caledon Chemicals, Georgetown, Ontario, Canada
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Biobreeding Labs, Ottawa, Ontario, 150-200 g, acclimated for 1 week, temperature 21 +/- 2 °C, humidity 40-70 %, caged individually and allowed free access to food and water
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- administration at a constant volume of 5 mL/kg, animals were fasted overnight before dose administration
- Doses:
- 546, 765, 1071, 1500, 2100 mg/kg body weight
- No. of animals per sex per dose:
- 10 males, 10 females
- Control animals:
- no
- Details on study design:
- To establish the dose levels to be used in the LD50 studies, groups of two animals were administered test compounds at 250 and 3000 mg/kg and the mortality data were recorded. Then, the main LD50 studies were carried out with doses of 546-2100 mg/kg using 10 female and 10 male rats. Clinical observations were made for 14 days after dosing and a postmortem examination was performed on animals which died during this period. All surviving animals were killed at the end of 14 days and subjected to gross pathologic examination.
- Statistics:
- Statistical analysis of data was carried out using one-way analysis of variance and the Student-Newman-Keuls test. LD50 values were calculated using the probit analysis (Finney 1952).
Results and discussion
Effect levelsopen allclose all
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 908 mg/kg bw
- 95% CL:
- 750 - 1 082
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 117 mg/kg bw
- 95% CL:
- 843 - 1 514
- Mortality:
- See also Table 1: At the highest dose level, 4 males died within 24 hours after dosing and most animals were dead after 4 days post-administration. At lower doses animals died primarily on Day 3 to Day 4 post-administration.
- Clinical signs:
- other: Common clinical signs consisted of piloerection, sedation, flaccid muscle tone, ataxia, and prostration. Chloroform elicited dacryorrhea in some animals.
- Gross pathology:
- Increased relative weights of the liver and the kidneys. For lesions see Table 2
- Other findings:
- A clear trend towards increased cholesterol levels was seen in all treated animals. Inhibition of lactate dehydrogenase activities were seen in all treated groups. A significant decrease in the levels of liver proteins were observed in rats fed chloroform. Microsomal hydroxylase activity of female but not male rats was activated by administration of chloroform. A reduction in lymphocytes with significant decreased was noted in female rats. Decrease in haemoglobin and haematocrit values were observed in males and females fed chloroform.
Any other information on results incl. tables
Table 1: Mortality occurring in the acute oral toxicity study:
Dose (mg/kg) |
Sex |
Total animals dead* |
Survival time (days after oral administration) |
LD50 (mg/kg) |
||||||
1 |
2 |
3 |
4 |
5 |
6 |
7 |
||||
546 |
Male |
0 |
-- |
-- |
-- |
-- |
-- |
-- |
-- |
M:908(750-1082) F:1117(843-1514) |
Female |
1 |
-- |
-- |
1 |
-- |
-- |
-- |
-- |
||
765 |
Male |
5 |
1 |
-- |
1 |
1 |
2 |
-- |
-- |
|
Female |
3 |
-- |
-- |
1 |
2 |
-- |
-- |
-- |
||
1071 |
Male |
6 |
2 |
-- |
2 |
-- |
2 |
-- |
-- |
|
Female |
6 |
-- |
2 |
2 |
-- |
-- |
2 |
-- |
||
1500 |
Male |
9 |
-- |
-- |
5 |
1 |
2 |
1 |
-- |
|
Female |
5 |
-- |
1 |
3 |
1 |
-- |
-- |
-- |
||
2100 |
Male |
10 |
4 |
-- |
3 |
1 |
1 |
1 |
-- |
|
Female |
9 |
-- |
-- |
4 |
5 |
-- |
-- |
-- |
*Animals dying before the end of the 14 day observation period
Table 2: Incidence of histological changes of rats which survived single oral doses of chloroform
Doses (mg/kg) |
Liver |
Kidneys |
||
Males |
Females |
Males |
Females |
|
546 |
0/2 |
1/2 |
02 |
0/2 |
765 |
2/2 |
0/2 |
1/2 |
1/2 |
1071 |
-- |
0/2 |
-- |
2/2 |
1500 |
0/1 |
0/2 |
0/1 |
1/2 |
2100 |
-- |
0/1 |
-- |
0/1 |
Numbers denote: number of animals showing lesions/animals examined
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Remarks:
- Migrated information
- Conclusions:
- Based on the results of this study in the rat, chloroform is classified as harmful if swallowed.
- Executive summary:
The acute oral toxicity of chloroform, solubilised in corn oil, was tested in female and male Sprague-Dawley rats (10 animals per dose group) in accordance with the OECD Guideline No. 401 with minor restrictions. Chloroform was administered at doses of 546, 765, 1071, 1500 and 2100 mg/kg body weight by oral gavage. Animals were then observed for 14 hours, clinical signs were noted and animals which were dying during the observation period or were killed after 14 days were submitted to necropsy and gross pathology. The mean LD50 values determined for male rats was 908 mg/kg body weight, that of female rats was 1117 mg/kg. Following the GHS classification system, chloroform on the basis of the present study is classified into Toxicity Category IV, receiving the hazard statement "harmful if swallowed".
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.